SAN FRANCISCO, Jan. 13, 2021 /PRNewswire-PRWeb/ — Paubox, a market leader in the HIPAA compliant email space, announced today a $4 million Series A funding led by Arthur Ventures (AV). Patrick Meenan, Partner at AV, led the investment and joined the Company’s board of directors.
Paubox is used by over 3,000 paying customers to solve their email security and compliance requirements in U.S. healthcare. Unlike incumbent solutions that force recipients to login to a portal to read a secure message, Paubox allows the recipient to read a secure, compliant email in their inbox, just like a normal message.
With a Net Promoter Score (NPS) of 80 and HITRUST CSF certification for its core products, the company has uncovered strong product-market fit in the healthcare vertical. The company was founded by Hoala Greevy in 2014 and employs 34 people out of its headquarters in San Francisco.
Hoala Greevy, Founder CEO of Paubox said: “The timing of our Series A funding is impeccable. We will continue to provide market leadership in the HIPAA compliant email space, as more Americans than ever depend on their healthcare providers to provide secure and frictionless communication.”
Patrick Meenan, Partner at Arthur Ventures said: “We think Paubox is the best product on the market. High NPS and terrific customer retention is a fantastic combination and we’re excited to be partnering with them.”
About Paubox
Paubox provides secure email for modern healthcare. Right out of the box. Paubox leads the HIPAA Compliant Email industry in three categories of the G2 Winter 2021 report: Best Email Encryption Software, Best HIPAA Compliant Messaging Software, and Best Secure Email Gateway Software. Coupled with its HITRUST CSF certification, customers can trust Paubox to provide them with seamless, secure, and compliant email solutions.
About Arthur Ventures
Arthur Ventures leads investments in B2B software companies in every region across North America and Western Europe.
Media Contact
Sierra Reed, Paubox, +1 415.795.7396 Ext: 819, press@paubox.com
SOURCE Paubox
CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…
MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…
Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…
PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…